“A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Guselkumab at 52 Weeks for the Treatment of Psoriatic Arthritis”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s312. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/2448.